Leucocyte esterase dip-stick test as a point-of-care diagnostic for urogenital chlamydia in male patients: A multi-center evaluation in two STI outpatient clinics in Paramaribo and Amsterdam

Abstract Background Point-of-care (POC) tests are an important strategy to address the epidemic of sexually transmitted infections (STIs). The leucocyte esterase test (LET) can be used as a POC test for chlamydia. The aim of this study was to determine the diagnostic accuracy of the LET to detect ur...

Full description

Bibliographic Details
Main Authors: Menne Bartelsman, Henry J. C. de Vries, Maarten F. Schim van der Loeff, Leslie O. A. Sabajo, Jannie J. van der Helm
Format: Article
Language:English
Published: BMC 2016-11-01
Series:BMC Infectious Diseases
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12879-016-1946-8
id doaj-9ab974156ddb4b8fb3630ff54fc84525
record_format Article
spelling doaj-9ab974156ddb4b8fb3630ff54fc845252020-11-25T03:23:39ZengBMCBMC Infectious Diseases1471-23342016-11-011611810.1186/s12879-016-1946-8Leucocyte esterase dip-stick test as a point-of-care diagnostic for urogenital chlamydia in male patients: A multi-center evaluation in two STI outpatient clinics in Paramaribo and AmsterdamMenne Bartelsman0Henry J. C. de Vries1Maarten F. Schim van der Loeff2Leslie O. A. Sabajo3Jannie J. van der Helm4Department of Infectious Diseases, STI Outpatient Clinic, Public Health Service of Amsterdam (GGD Amsterdam)Department of Infectious Diseases, STI Outpatient Clinic, Public Health Service of Amsterdam (GGD Amsterdam)Center for Infection and Immunology Amsterdam (CINIMA), Academic Medical Center (AMC), University of AmsterdamDermatological Service, Ministry of Health SurinameDepartment of Infectious Diseases, STI Outpatient Clinic, Public Health Service of Amsterdam (GGD Amsterdam)Abstract Background Point-of-care (POC) tests are an important strategy to address the epidemic of sexually transmitted infections (STIs). The leucocyte esterase test (LET) can be used as a POC test for chlamydia. The aim of this study was to determine the diagnostic accuracy of the LET to detect urogenital chlamydia among men at STI clinics in Paramaribo, Suriname and Amsterdam, the Netherlands. Methods Recruitment of patients took place in 2008–2010 in Suriname and in 2009–2010 in the Netherlands. Urine of patients was examined with the LET. The reference test was a nucleic acid amplification test (NAAT). Results We included 412 patients in Suriname and 645 in the Netherlands. Prevalence of chlamydia in Suriname and the Netherlands was respectively 22.8 and 13.6 %. The sensitivity of the LET was 92.6 % (95 % CI = 85.3–97.0) and 77.3 % (95 % CI = 67.1–85.5) respectively, the specificity was 38.1 % (95 % CI = 32.7–43.6 %) and 58.1 % (95 % CI = 53.9–62.3) respectively. The positive predictive value was 30.6 % (95 % CI = 27.3–36.4) and 22.6 % (95 % CI = 18.0–27.7) respectively and the negative predictive value was 94.5 % (95 % CI = 89.1–97.8) and 94.2 % (95 % CI = 91.1–96.4) respectively. The kappa was respectively 0.179 and 0.176. Conclusions To diagnose urogenital chlamydia in men the LET performs poorly. It has a high negative but low positive predictive value. If the LET result is negative, chlamydia is accurately excluded, yet a positive result has a low predictive value. Whether the advantages of direct management based on LET outweigh the disadvantages of overtreatment is a subject for further studies.http://link.springer.com/article/10.1186/s12879-016-1946-8SensitivitySpecificityChlamydiaPoint-of-care testLeucocyte esterase testChlamydia trachomatis
collection DOAJ
language English
format Article
sources DOAJ
author Menne Bartelsman
Henry J. C. de Vries
Maarten F. Schim van der Loeff
Leslie O. A. Sabajo
Jannie J. van der Helm
spellingShingle Menne Bartelsman
Henry J. C. de Vries
Maarten F. Schim van der Loeff
Leslie O. A. Sabajo
Jannie J. van der Helm
Leucocyte esterase dip-stick test as a point-of-care diagnostic for urogenital chlamydia in male patients: A multi-center evaluation in two STI outpatient clinics in Paramaribo and Amsterdam
BMC Infectious Diseases
Sensitivity
Specificity
Chlamydia
Point-of-care test
Leucocyte esterase test
Chlamydia trachomatis
author_facet Menne Bartelsman
Henry J. C. de Vries
Maarten F. Schim van der Loeff
Leslie O. A. Sabajo
Jannie J. van der Helm
author_sort Menne Bartelsman
title Leucocyte esterase dip-stick test as a point-of-care diagnostic for urogenital chlamydia in male patients: A multi-center evaluation in two STI outpatient clinics in Paramaribo and Amsterdam
title_short Leucocyte esterase dip-stick test as a point-of-care diagnostic for urogenital chlamydia in male patients: A multi-center evaluation in two STI outpatient clinics in Paramaribo and Amsterdam
title_full Leucocyte esterase dip-stick test as a point-of-care diagnostic for urogenital chlamydia in male patients: A multi-center evaluation in two STI outpatient clinics in Paramaribo and Amsterdam
title_fullStr Leucocyte esterase dip-stick test as a point-of-care diagnostic for urogenital chlamydia in male patients: A multi-center evaluation in two STI outpatient clinics in Paramaribo and Amsterdam
title_full_unstemmed Leucocyte esterase dip-stick test as a point-of-care diagnostic for urogenital chlamydia in male patients: A multi-center evaluation in two STI outpatient clinics in Paramaribo and Amsterdam
title_sort leucocyte esterase dip-stick test as a point-of-care diagnostic for urogenital chlamydia in male patients: a multi-center evaluation in two sti outpatient clinics in paramaribo and amsterdam
publisher BMC
series BMC Infectious Diseases
issn 1471-2334
publishDate 2016-11-01
description Abstract Background Point-of-care (POC) tests are an important strategy to address the epidemic of sexually transmitted infections (STIs). The leucocyte esterase test (LET) can be used as a POC test for chlamydia. The aim of this study was to determine the diagnostic accuracy of the LET to detect urogenital chlamydia among men at STI clinics in Paramaribo, Suriname and Amsterdam, the Netherlands. Methods Recruitment of patients took place in 2008–2010 in Suriname and in 2009–2010 in the Netherlands. Urine of patients was examined with the LET. The reference test was a nucleic acid amplification test (NAAT). Results We included 412 patients in Suriname and 645 in the Netherlands. Prevalence of chlamydia in Suriname and the Netherlands was respectively 22.8 and 13.6 %. The sensitivity of the LET was 92.6 % (95 % CI = 85.3–97.0) and 77.3 % (95 % CI = 67.1–85.5) respectively, the specificity was 38.1 % (95 % CI = 32.7–43.6 %) and 58.1 % (95 % CI = 53.9–62.3) respectively. The positive predictive value was 30.6 % (95 % CI = 27.3–36.4) and 22.6 % (95 % CI = 18.0–27.7) respectively and the negative predictive value was 94.5 % (95 % CI = 89.1–97.8) and 94.2 % (95 % CI = 91.1–96.4) respectively. The kappa was respectively 0.179 and 0.176. Conclusions To diagnose urogenital chlamydia in men the LET performs poorly. It has a high negative but low positive predictive value. If the LET result is negative, chlamydia is accurately excluded, yet a positive result has a low predictive value. Whether the advantages of direct management based on LET outweigh the disadvantages of overtreatment is a subject for further studies.
topic Sensitivity
Specificity
Chlamydia
Point-of-care test
Leucocyte esterase test
Chlamydia trachomatis
url http://link.springer.com/article/10.1186/s12879-016-1946-8
work_keys_str_mv AT mennebartelsman leucocyteesterasedipsticktestasapointofcarediagnosticforurogenitalchlamydiainmalepatientsamulticenterevaluationintwostioutpatientclinicsinparamariboandamsterdam
AT henryjcdevries leucocyteesterasedipsticktestasapointofcarediagnosticforurogenitalchlamydiainmalepatientsamulticenterevaluationintwostioutpatientclinicsinparamariboandamsterdam
AT maartenfschimvanderloeff leucocyteesterasedipsticktestasapointofcarediagnosticforurogenitalchlamydiainmalepatientsamulticenterevaluationintwostioutpatientclinicsinparamariboandamsterdam
AT leslieoasabajo leucocyteesterasedipsticktestasapointofcarediagnosticforurogenitalchlamydiainmalepatientsamulticenterevaluationintwostioutpatientclinicsinparamariboandamsterdam
AT janniejvanderhelm leucocyteesterasedipsticktestasapointofcarediagnosticforurogenitalchlamydiainmalepatientsamulticenterevaluationintwostioutpatientclinicsinparamariboandamsterdam
_version_ 1724605163016028160